Cholinergic synaptic signaling

Cholinergic synaptic signaling is a complex neurotransmission system centered on the neurotransmitter acetylcholine (ACh), which plays a vital role in both the central and peripheral nervous systems (PMC9571640). In the brain, this pathway is essential for high-level cognitive processes, including memory, learning, attention, and arousal, while in the periphery, it governs muscle contraction at the neuromuscular junction and regulates autonomic functions through the parasympathetic nervous system (PMC8911411). The signaling process involves the synthesis of ACh by choline acetyltransferase, its vesicular storage, and its eventual release into the synapse where it activates nicotinic (ionotropic) and muscarinic (metabotropic) receptors (PubMed). Termination of the signal occurs through the rapid enzymatic degradation of ACh by acetylcholinesterase (StatPearls). Dysfunction or degeneration of cholinergic neurons is a primary pathological feature of Alzheimer's disease and other dementias, leading to significant cognitive impairment (PMC5991350). Therapeutic interventions often focus on enhancing cholinergic tone, primarily through the use of acetylcholinesterase inhibitors like donepezil, or by directly modulating receptor activity to treat conditions ranging from glaucoma and myasthenia gravis to various psychiatric disorders (PMC8911411).

Other names

Cholinergic synapseCholinergic neurotransmissionAcetylcholine signaling pathwayCholinergic system

Drugs targeting this pathway primarily act by inhibiting acetylcholinesterase to increase synaptic acetylcholine levels or by serving as agonists or antagonists at nicotinic and muscarinic acetylcholine receptors (PMC9571640, StatPearls).